427 filings
Page 4 of 22
8-K
bqscisbfui vr
3 Nov 21
Results of Operations and Financial Condition
7:30am
8-K
5omyh cliy
4 Aug 21
Second-Quarter Revenue of $914.6 Million
7:30am
SD
mvl mmmb2efbkydi6ss
28 May 21
Conflict minerals disclosure
6:05am
8-K
eq4duhrbi4ydbmpwa
18 May 21
Amended and Restated Employment Agreement
4:16pm
8-K
skointhea3
10 May 21
Submission of Matters to a Vote of Security Holders
5:19pm
S-3ASR
4axl k54w4mmqcoo1dd
4 May 21
Automatic shelf registration
4:28pm
8-K
cyyfzkt 1p
4 May 21
Results of Operations and Financial Condition
7:30am
8-K
rbm2a7uzy00 bglmot
23 Apr 21
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:01pm
8-K
gbuv5 nad3
29 Mar 21
Charles River Laboratories Completes the Acquisition of Cognate Bioservices
5:18pm
8-K
e70e4w
23 Mar 21
Charles River Laboratories Announces Closing of Senior Notes Offering
4:42pm
8-K
n5kb2em72pie64ytg
9 Mar 21
Charles River Laboratories Announces Planned Offering of $1 Billion of Senior Notes
8:59am
8-K
adfgn
17 Feb 21
Entry into a Material Definitive Agreement
4:03pm
8-K
qbjk1gbf9l10vdd
17 Feb 21
Results of Operations and Financial Condition
7:30am
UPLOAD
lqbkez4
31 Dec 20
Letter from SEC
12:00am
CORRESP
rmi71rv80erk
17 Dec 20
Correspondence with SEC
12:00am
UPLOAD
yke4cbm
7 Dec 20
Letter from SEC
12:00am